Page last updated: 2024-08-24

tepoxalin and Kidney Diseases

tepoxalin has been researched along with Kidney Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrett, DS; Dempster, AM; Keenan, CM; Kimball, JP; Knight, EV; Lieuallen, WG; Panigrahi, D; Powers, WJ; Smith, IL; Szot, RJ; Wong, FA	1

Other Studies

1 other study(ies) available for tepoxalin and Kidney Diseases

Article	Year
Preclinical toxicity evaluation of tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, in Sprague-Dawley rats and beagle dogs. Fundamental and applied toxicology : official journal of the Society of Toxicology, 1996, Volume: 33, Issue:1 Topics: Absorption; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Chemistry, Clinical; Cyclooxygenase Inhibitors; Dogs; Female; Hematologic Tests; Kidney Diseases; Lipoxygenase Inhibitors; Male; Organ Size; Pyrazoles; Rats; Rats, Sprague-Dawley; Survival Rate	1996

Article

Year

Preclinical toxicity evaluation of tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, in Sprague-Dawley rats and beagle dogs.

Fundamental and applied toxicology : official journal of the Society of Toxicology, 1996, Volume: 33, Issue:1

Topics: Absorption; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Chemistry, Clinical; Cyclooxygenase Inhibitors; Dogs; Female; Hematologic Tests; Kidney Diseases; Lipoxygenase Inhibitors; Male; Organ Size; Pyrazoles; Rats; Rats, Sprague-Dawley; Survival Rate

1996